New Hampshire: Many Fear More HIV/AIDS Drug Coverage Cuts
May 2, 2005
The New Hampshire AIDS Drug Assistance Program's (ADAP) 331 clients received letters last fall stating that they would continue to receive AIDS drugs, but expensive medications to fight side effects and other complications would no longer be covered. Last year, the federal government cut the state's ADAP grant by 5 percent, while drug costs leapt by 47 percent, to some $9,300 per patient annually. By December, New Hampshire's ADAP will be nearly $1.8 million in the red.Adapted from:
"That's a recipe for disaster," said Dr. William Kassler, state medical director. With possible federal budget tightening and continued drug price increases, things could get worse, said Kassler. Even some drugs that have been on the market for years are suddenly more expensive. "The drug companies feel that the market will bear this," said Kassler. "They can charge that, and people have no option but to pay."
Kassler's most difficult decision was related to the expensive, last-line AIDS drug Fuzeon, which the state can only afford for two patients. There is already one patient on the Fuzeon waiting list. "It's an ethical conundrum," said Kassler. "How can you look this guy in the face and say we can't give you this medication? But how can you look at other folks and say we can't give you your medication [because Fuzeon is so expensive]?"
ADAP clients say lobbying lawmakers for more federal funds is hard when the state contributes none of its own funds. However, Gov. John Lynch has included $180,000 for ADAP in his proposed budget. Additionally, state legislators are considering creating a committee to assess the needs of state residents with AIDS.
04.28.05; Meg Heckman
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.